Scientific Team

Eric Olson, PhD Scientific Founder and Board Observer

Eric Olson, PhD, is Professor and Chair of the Department of Molecular Biology at the University of Texas Southwestern Medical Center in Dallas, where he also holds the Robert A. Welch Distinguished Chair in Science, the Annie and Willie Nelson Professorship in Stem Cell Research, and the Pogue Distinguished Chair in Research on Cardiac Birth Defects. Dr. Olson has dedicated his career to deciphering the mechanisms that control development and disease of the heart, cardiovascular system and skeletal muscle tissue. Dr. Olson has co-founded multiple biotechnology companies to translate basic discoveries into new therapeutics for muscle disease, and is a member of the National Academy of Sciences, the National Academy of Medicine and the American Academy of Arts and Sciences.

Leonela Amoasii, PhD Director of Research

Leonela Amoasii, PhD, has worked in the laboratory of Dr. Eric Olson at the University of Texas Southwestern Medical Center in Dallas since 2012. Dr. Amoasii obtained her undergraduate degree in Molecular Biology and Biochemistry and master degree in Molecular and Cellular Physiopathology at the Louis Pasteur University in Strasbourg, France. Dr. Amoasii pursued her graduate studies at the Institut de Génétique Biologie Moléculaire et Cellulaire (IGBMC) at the University of Strasbourg in France. During her doctoral studies, she identified the mechanistic basis of myotubular centronuclear myopathy and acquired expertise in the use of adeno-associated virus (AAV) for manipulation of gene expression in muscle. Over the last years Dr. Amoasii has been involved in developing a new therapeutic approach for correction of Duchenne muscular dystrophy using CRISPR/Cas9 genomic editing. Dr. Amoasii pursued the in vivo optimization of the CRISPR/Cas9 genomic editing, her recent work reveals promising results for translation of the genome editing technology to human patients.